Advantage of ostarine over raloxifene and their combined treatments for muscle of estrogen-deficient rats.

J Endocrinol Invest · 2024 · PMC10904410 · PMID 37672168

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly non-significantno p-value reported

In our study, neither OST nor RAL was shown to affect the amount of myonuclei, although in general all OVX groups had a slightly non-significant higher ratio of myonuclei in muscle than Non-OVX rats.

also in 39 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.